[Treatment results in patients with mitral valve disease in IV functional class of NYHA. I. Surgical treatment].
In the group of 142 patients with mitral valve disease (61% in IV and 39% in III functional class of NYHA) the efficacy of mitral valve replacement (MVR) was analysed. In all of the patients clinical, noninvasive and invasive investigations were obtained and compared before an after surgery. After MVR a statistically significant differences (p < 0.05 or p < 0.01) of RHV, noninvasive and hemodynamic data was observed. The survival during ca 1836 days after surgery of patients in IV class of NYHA was 72%. The improvement of activities correlated well with changes of functional class of NYHA.
Rawczyńska-Englert
I
I
I Kliniki Wad Serca Instytutu Kardiologii, Warszawie.
D000328:Adult; D000368:Aged; D005260:Female; D006349:Heart Valve Diseases / Q000503:physiopathology / Q000601:surgery; D006350:Heart Valve Prosthesis; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*
Wyniki leczenia chorych z wada mitralna w IV okresie czynnościowym wg NYHA. Cześć I: Leczeni operacyjnie.